Review
Open access
2026
FDG PET/CT in the post-treatment evaluation of breast cancer: an emphasis on triple-negative breast cancer.
Triple-negative breast cancer (TNBC) is an aggressive subtype accounting for 10-17% of all breast cancers, characterized by the absence of estrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2 expression. TNBC is associated with high recurrence rates and poor prognosis, particularly aft...
Shreeya H. Gandhi, J. Gujral, A. Amanullah et al.
· American Journal of Nuclear... · 0 citations